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ABSTRACT: Twenty dogs received a potentially lethal (15 mg/kg) dose of brodifacoum, a halogenated coumarin-type 
anticoagulant poison. Eleven were immediately treated with vitamin K: daily for 5 days, either by intramuscular injections 
(2 mg/kg) or oral tablets (1 mg/kg). It was necessary to give further doses of vitamin Kj to most of the dogs for up to 2 weeks 
after the first treatment period to reduce their P times to normal levels (<10 seconds). Four dogs were not given further vitamin 
Kj and two of these died of acute blood loss from an intrathoracic hemorrhage. Nine dogs received vitamin K: (2 mg/kg by 
intramuscular injection) when clinical signs of anticoagulant poisoning were observed. Two dogs died suddenly without pre-
monitory clinical signs of poisoning. The remaining 7 dogs showed various signs of anticoagulant poisoning 4 to 8 days after 
dosing and they received a 5 day course of vitamin Kr After this period one dog had a transient rise in its P time but this 
returned to normal without treatment, while another dog was treated on days 16,20,29 and 30. In conclusion, the authors 
recommended vitamin K: therapy, 2 mg/kg by tablet or injection, daily for 3 weeks in cases of known or suspected 
brodifacoum poisoning in dogs. 
Proc. Vertebr. Pest Conf. (A.C. Crabb and R.E. Marsh, Eds.), 
Printed at Univ. of Calif., Davis. 13:86-90, 1988 
INTRODUCTION 
Brodifacoum, a halogenated coumarin derivative, is 
currently marketed as a rodenticide and has recently been 
shown to be suitable for rabbit control under New Zealand 
conditions (Godfrey and Lyman 1980, Godfrey etal. 1981a, 
Rammelletal. 1984). The most commonly used poison to 
control rabbits at the moment is sodium monofluoroacetate 
(1080), and dogs, which are highly susceptible to this poison, 
frequently die after ingesting bait material or poisoned 
animals (Rammell and Fleming 1978). Death usually occurs 
within 12 hours and there is no antidote. Brodifacoum is 
considerably less toxic for dogs than 1080 (LD50 3.56 and 0.5 
mg/kg respectively) whereas the LD50 in rabbits is very 
similar (0.5 and 0.7 mg/kg respectively) (Mount et al. 1982, 
Godfrey etal. 1981b, Rammell and Fleming 1978). Thus the 
riskof adog ingesting a lethal dose of brodifacoum is less than 
for 1080. Commercial baits contain 50 mg brodifacoum per 
kg bait and therefore a 20-kg dog would have to consume 1.5 
kg of bait to receive an acute LD50 dose. However, there is 
considerable variation between individuals in their response 
to anticoagulant poisoning (Coon and Willis 1970) and some 
dogs may be clinically affected with smaller doses. A number 
of dogs have been poisoned after consuming as few as 8 Talon 
baits (Montgomery, pers. comm.). As with all anticoagulant 
poisons there is a 2- to 3-day delay before a fall in blood 
clotting factors and the onset of clinical signs which may 
include lassitude, anorexia, a bloody nasal discharge, rapid 
thready pulse, pallid mucous membranes, rapid respiration 
and petechial hemorrhages in the oral and conjunctival 
mucous membranes. These signs should alert the owner and 
veterinarian to the possibility of anticoagulant poisoning. 
All anticoagulants derived from coumarin are structur-
ally related to vitamin K and interfere with the normal blood-
clotting mechanism by inhibiting the vitamin K dependent 
synthesis of clotting factors II (prothrombin), VII, IX and X 
(Park et al. 1979). Thus measurement of the prothrombin 
time (P time) is a good indication of the degree of anticoagu-
lantactivity. The normal P time for a dog is < 10 seconds. The 
administration of vitamin Kl appreciably reduces a pro-
longed prothrombic time within 4 to 8 hours of administra-
tion. Vitamin KL acts on a competitive basis and larger doses 
are required to reverse higher doses of anticoagulant (Coon 
and Willis 1970). There are a number of similar analogues 
of naturally occurring Vitamin K, which are reputed to have 
the same activity. However, Clark and Halliwell (1963) 
demonstrated that a number of commercially available wa-
ter- soluble analogues, such as vitamin K3, have little or no 
value for treating anticoagulant poisoning. This is probably 
because of their more rapid conjugation and excretion (Coon 
and Willis 1970). 
The "first generation" anticoagulant rodenticides of the 
coumarin type include warfarin, and their activity lasts for up 
to 4 days (Coon and Willis 1970, Mount et al. 1982); 
therefore, vitamin K, therapy (1 to 2 mg/kg) daily for a 
minimum of 4 days has been recommended (Clark and 
Halliwell 1963). "Second generation" anticoagulants such as 
brodifacoum appear to be cleared from the body more slowly 
and they are pharmacologically active longer. Tissue resi-
dues have been detected in the livers of sheep for up to 4 
months after they were dosed with brodifacoum at 2 mg/kg, 
86 
although these animals showed no clinical signs of anticoagu-
lant poisoning (Laas et al. 1985). Anticoagulant activity has 
been detected in rabbits 6 weeks after they were dosed with 1 
mg/kg brodifacoum (Park and Leek 1982). However there is 
no published information on the duration of brodifacoum 
activity in dogs nor on the recommendations for treatment of 
dogs poisoned with it. Therefore, the objective of this trial was 
to investigate the dose and duration of vitamin Kt necessary to 
treat dogs acutely poisoned with a potentially lethal dose of 
brodifacoum. 
MATERIALS AND METHODS 
Twenty-one dogs of mixed age, breed and sex were 
individually housed in kennels, fed mutton daily and had water 
freely available. They all received a sandwich of bread and 
margarine containing brodifacoum at a dose rate of 15 mg/kg 
which is approximately 4 times the LD50 (Godfrey et al. 
1981b). There were 3 treatment regimes: Group 1: Five 
dogs received vitamin Kt (2 mg/kg) by intramuscular (IM) 
injection daily for 5 days commencing the day after dosing. 
(The source of Kt was Konakion - Roche Products (New 
Zealand) Ltd, Auckland, New Zealand). Group 2: Six dogs 
received vitamin Kj (1 mg/kg) orally by tablet daily for 5 
days commencing the day after dosing. Group 3: Ten dogs 
were observed daily for obvious clinical signs of 
anticoagulant poisoning, which an owner would be likely to 
detect, e.g., dullness, inappetence, spontaneous bleeding 
from orifices, sudden appearance of subcutaneous swelling, 
or hemorrhages in the oral mucosa. Treatment commenced 
immediately clinical signs appeared and constituted daily IM 
injections of vitamin Kj (2 mg/kg) for 5 days. 
Based on the results of a previous trial (Godfrey, unpubl.) 
it was estimated that5 days' therapy would be sufficiently long 
to reverse brodifacoum poisoning. However, it soon became 
apparent that 5 days was not long enough. A number of dogs 
became clinically affected a few days after the initial period 
of treatment ended and further vitamin Kj doses were given 
when indicated by the development of clinical signs or pro-
longed P times. Four dogs chosen at random served as 
controls to assess the severity of the relapse: dogs 40 and 51 
in Group 1; 58 and 61 in Group 2. 
Blood samples were taken using citrated vacutainers at 
2 to 3 day intervals throughout the trial for determination of 
P times using Simplastin obtained from William R. Warner, 
Ltd. 
RESULTS 
Group 1
(Table 1) The P times during the initial treatment period 
rose slightly but did not exceed 11 seconds. Atday 8,3 days 
after the initial treatment ceased, P times rose markedly in 
4 of5 dogs and by day 11 the fifth dog'sPtimehadalso risen. 
Further treatments were given up to 20 days after dosing as 
indicated. One of the control dogs (40) died on day 18 while 
the other control dog (51) and the 3 treated dogs survived. 
Group 2
(Table 2) P times for 2 of the 6 dogs exceeded 11 
seconds during the first 5 days of therapy. Further treatments 
were given up to 22 days after dosing as indicated. A control 
dog (58) died on day 10, despite receiving treatment on day 
9, when it showed signs of acute blood loss. All other dogs 
survived. 
(Table 3) One dog (35) vomited its sandwich the eve-
ning after the trial commenced and had normal P times 
despite receiving no treatment. Two dogs (45 and 52) were 
found dead on days 3 and 5 without showing any abnormal 
clinical signs. Dog 45 was a pregnant bitch which had 
started whelping prematurely in the night and was found 
dead the next day after hemorrhaging from the uterus. The 
remaining 7 dogs all showed a variety of clinical signs of 
anticoagulant poisoning which included inappetence, frank 
hemorrhaging from nose or mouth, blood in the faeces or 
petechial hemorrhages in the oral or conjunctival mem-
branes.   The 5-day treatments commenced immediately 
Table 1. Porthrombin times (seconds) and occasions (*) when dogs were treated with Vitamin Kt (intramuscular injection 
2mg/kg) commencing the day after they received brodifacoum (15 mg/kg). 
N = Normal (<10 second prothrombin times) D 
= Dead 
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Table 2. Prothrombin times (seconds) and occasions (*) when dogs were treated with Vitamin Kj (oral tablets 1 mg/kg) 
commencing the day after they received brodifacoum (15 mg/kg). 
 
after these signs were first observed between days 4 and 8. 
Additional treatments were given to dog 41 when the P times 
rose above 15 seconds. All other dogs' P times remained at 
normal levels after the 5-day treatment except for dog 39 
which went up to 14 seconds on day 18 but returned to normal 
levels by day 20 without further treatment. None of the dogs 
showed clinical signs of anticoagulant poisoning subsequent 
to the 5-day treatment period. 
Postmortem examinations of dogs 40, 58 and 52 showed 
massive intrathoracic hemorrhage. 
Table 3. Prothrombin times (seconds) and occasions (*) when dogs were treated with Vitamin Kj (intramuscular injection 2 
mg/kg) commencing when clinical signs of brodifacoum poisoning appeared. 
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DISCUSSION 
The dose rate of brodifacoum used in this experiment is 
potentially lethal for most dogs, being 4 times the LD50 and 
equivalent to an LD90 (Godfrey et al. 1981b). 
It was calculated to be the maximum acute dose a dog 
could reasonably consume at one time in the form of baits 
(i.e., 6-kg baits for a 20-kg dog). However, it would be 
relatively easy for this dose to be consumed over a period of 
a few days. 
The trial was designed so that Groups 1 and 2 mimicked 
immediate prophylactic treatment while Group 3 represented 
the emergency treatment of dogs which have developed 
obvious clinical signs of anticoagulant poisoning. The results 
show that in the case of immediate prophylactic therapy a 4-
5 day vitamin K regime as recommended for treating warfarin 
poisoning in dogs (Clark and Halliwell 1963, Mount et al. 
1982) is of insufficient duration in cases of brodifacoum 
poisoning. 
The results also suggest that oral therapy with vitamin Kl
at a dose rate of 1 mg/kg is insufficient to maintain normal P 
times in dogs which have received a high dose of brod-
ifacoum. Clark and Halliwell (1963) demonstrated that oral 
and injectable forms of vitamin Kx therapy both produced 
similar effects although the intramuscular route gave a 
slightly slower onset of action but appeared to have a slightly 
more prolonged effect. They concluded that with both routes 
dosage at 24-hour intervals should be sufficient. They 
recommended dose rates of 1 to 2 mg/kg to treat warfarin 
poisoning. The present trials suggest that 2 mg/kg for both 
oral and injectable routes should be used in cases of brod-
ifacoum poisoning. 
The 2 deaths in Group 3 demonstrate how rapidly the 
coagulation factors can be depleted leading to acute, massive 
hemorrhage and highlight the susceptibility of pregnant 
bitches to hemorrhage at whelping. 
In most cases 5 days' treatment of the clinically affected 
dogs was sufficient and suggests that there is little brod-
ifacoum activity after 10 or 11 days. Two dogs, whose last 
treatments were on days 8 and 10, each had a transient rise in 
P times 3 to 8 days later. Dog 39 returned to normal 2 to 3 days 
later without treatment. However, dog 41 was treated on days 
16, 20, 29 and 30, although not all of these may have been 
necessary as some of the Simplastin tests failed to clot, and 
the results appear to be anomalous because the animal 
showed no clinical signs of poisoning despite very prolonged 
P times. 
RECOMMENDATIONS 
If a dog is known or thought to have eaten baits or dead 
animals containing brodifacoum, then vitamin Kj therapy, 2 
mg/kg either by IM injection or oral tablets, should be given 
daily for 3 weeks. Periodic blood samples for P time 
measurement may be taken to monitor the effectiveness of 
the treatment. 
If a dog develops clinical signs of anticoagulant poison-
ing, it must now be assumed to be due to brodifacoum and 
treated accordingly. If the dog shows signs of acute massive 
hemorrhage, then it is advisable to give a transfusion of whole 
blood or plasma which should immediately supply he-
mostalic concentrations of clotting factors. The amount 
transferred should approximate 5-10% of the patient's total 
blood volume, which is approximately 90 ml/kg (Mount etal. 
1982). In cases of hemothorax the blood should be aspirated 
and autotransfusion (where aspirated blood plus vitamin K:
is transfused back into the dog) may be performed (Crispin 
1977). In acute cases, vitamin K, (1 mg/kg) diluted with 
saline may be given by slow intravenous injection, and prior 
administration of an antihistamine is recommended to pre-
vent histaminoid reactions (Clark and Halliwell 1963, 
Crispin 1977). This should restore a proportion of clotting 
factors within 2 hours. Tablets or intramuscular injections of 
vitamin K; may be used initially in less acute cases. Vitamin 
Kj therapy by IM injection or oral tablets (2 mg/kg) should 
continue for 3 weeks. The effectiveness of the therapy can be 
monitored by measuring the P time. Pregnant bitches close 
to whelping should receive particular attention to assure that 
their P time is <10 seconds when whelping begins. 
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